This article has Open Peer Review reports available.
Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells
© The Author(s). 2017
Received: 9 December 2016
Accepted: 24 March 2017
Published: 29 March 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|9 Dec 2016||Submitted||Original manuscript|
|3 Jan 2017||Reviewed||Reviewer Report - Samuel Kerk|
|4 Jan 2017||Reviewed||Reviewer Report - Jamunarani Veeraraghavan|
|11 Feb 2017||Author responded||Author comments - Gerke Ariaans|
|Resubmission - Version 2|
|11 Feb 2017||Submitted||Manuscript version 2|
|16 Feb 2017||Reviewed||Reviewer Report - Samuel Kerk|
|2 Mar 2017||Reviewed||Reviewer Report - Jamunarani Veeraraghavan|
|16 Mar 2017||Author responded||Author comments - Gerke Ariaans|
|Resubmission - Version 3|
|16 Mar 2017||Submitted||Manuscript version 3|
|24 Mar 2017||Editorially accepted|
|29 Mar 2017||Article published||10.1186/s12885-017-3230-8|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.